Glinide Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Glinide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | REPAGLINIDE | repaglinide | TABLET;ORAL | 201189-003 | Jan 22, 2014 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Sun Pharm Inds Inc | REPAGLINIDE | repaglinide | TABLET;ORAL | 077571-003 | Jul 11, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 203820-001 | Jan 22, 2014 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Macleods Pharms Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 207209-001 | Mar 22, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 203820-002 | Jan 22, 2014 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Macleods Pharms Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 207209-002 | Mar 22, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Padagis Us | REPAGLINIDE | repaglinide | TABLET;ORAL | 201189-001 | Jul 17, 2013 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
